Cinnarizine
Description
Cinnarizine is a medicine that belongs to the category of antihistaminic medications. It is used to treat problems associated with the inner ear and the brain. This medicine is used to treat dizziness and sickness associated with motion sickness.
QUICK LINKS:
Side effects
Major & minor side effects for Cinnarizine
- Drowsiness
- Weight gain
- Indigestion
- Nausea or Vomiting
- Stomach discomfort and pain
- Excessive sweating
- Unusual tiredness and weakness
- Headache
- Dry mouth
- Twitching and unusual movement of muscles
- Yellowing of skin and eyes
- Excessive salivation
- Swelling of face, lips, eyelids, tongue, hands and feet
- Depressed mood
- Muscle stiffness and trembling
Uses of Cinnarizine
What is it prescribed for?
- Motion sickness
- Vertigo and vestibular disorders
- Heart and blood vessel disorder
Read More
Concerns
Commonly asked questions
- Onset of actionThe effect of this medicine can be observed within an hour of oral administration.
- Duration of effectThe effect of this medicine lasts for 6-8 hours in most cases.
- Safe with alcohol?Avoid or limit the uptake of alcohol while using this medicine. It is advised to refrain from driving a vehicle or operating a heavy machinery while taking this medicine.
- Is it habit forming?No habit forming tendencies were reported.
- Usage in pregnancy?This medicine is not recommended for use in pregnant women unless absolutely necessary. Consult your doctor and discuss the benefits and risks associated with the use of this medicine.
- Usage while breast-feeding?This medicine is not recommended for use by a breastfeeding woman unless absolutely necessary. Consult your doctor and discuss the benefits and risks associated with the use of this medicine. It is advised to discontinue breastfeeding while the medicine is being taken.
Allergy
This medicine is not recommended for use if you have a known history of allergy to Cinnarizine or any other component present along with it.
Depression
This medicine is not recommended for use if you suffer from depression or any other depressive disorders.
Porphyria
This medicine is not recommended for use in patients suffering from a rare genetic condition affecting the blood and the skin.
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. Consult your doctor and discuss the benefits and risks associated with the use of this medicine.
Breast-feeding
This medicine is not recommended for use by a breastfeeding woman unless absolutely necessary. Consult your doctor and discuss the benefits and risks associated with the use of this medicine. It is advised to discontinue breastfeeding while the medicine is being taken.
General warnings
Depression
Use of this medicine may cause lack of interest, low mood, sleep disturbances in some patients. It should be administered with caution in patients with an active/past instance of depression.
Drowsiness
Use of this medicine may cause drowsiness and sleepiness in some patients. It is advised to not perform any activity requiring a high level of mental alertness while taking this medicine.
Liver/kidney disease
This medicine should be used with caution in a patient having a liver disease or impairment of normal liver/kidney function.
Glaucoma
This medicine should be used with caution in patients having glaucoma. Report any instance of disturbance in vision, pain or dryness of eyes to the doctor immediately.
Pediatric use
This medicine is not recommended for use in children below 5 years of age.
Use in elderly
This medicine should be used with caution in the elderly as the risk of adverse effects are significantly high.
Fall in blood pressure
Use of high doses of this medicine may cause a fall in blood pressure and hence should be used with caution in patients suffering from hypotension.
Galactose intolerance
This medicine should not be used if you suffer from a genetic disorder causing intolerance to galactose or other sugars.
Missed Dose
Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose then the missed dose can be skipped.
Overdose
Contact your doctor immediately if an overdose with this medicine is suspected. Symptoms of an overdose may include drowsiness, tiredness, increased heart rate, mild agitation etc.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
Use of alcohol while taking this medicine may cause an excessive amount of drowsiness, sleepiness.
Instructions
Avoid or limit the uptake of alcohol while using this medicine. It is advised to refrain from driving a vehicle or operating a heavy machinery while taking this medicine.
Interaction with Medicine
Amitriptyline
Tramadol
Chlorpromazine
Diazepam
Disease interactions
Parkinson's disease
This medicine should be used with caution in patients suffering from Parkinson's disease. It should be used only when the potential benefits outweigh the risks involved with use.
Porphyria
This medicine is not recommended for use if you have a genetic disorder of the blood and skin (Porphyria). The risk of adverse effects are significantly high and hence your doctor may suggest a suitable alternative.
Food interactions
Information not available.
Lab interactions
Skin sensitivity test
Report the use of this medicine to the doctor before a skin sensitivity test. This medicine may interfere with the procedure and may give false negative results. Use of this medicine should stop at least 4 days before the test is conducted.
Take Cinnarizine as instructed by the doctor. This medicine can be taken after food. Take this medicine 2 hours prior to starting the travel. Do not take more than the recommended dose of this medicine.
Miscelleneous
How it works
This medicine acts on the vomiting center in the brain to prevent the sensation of vomiting.
Legal Status
Classification
Category
Antiemetic/antivertigo agents
Schedule
Schedule H
[Internet]. 2017 [cited 17 May 2017]. Available from:
Cinnarizine - DrugBank [Internet]. Drugbank.ca. 2017 [cited 17 May 2017]. Available from:
Cinnarizine | C26H28N2 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 17 May 2017]. Available from:
[Internet]. 2017 [cited 16 November 2017]. Available from:
Information on this page was last updated on 16 Nov 2017
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.